Hyun-soo Cho

Molecular Biology · 2003–2018

A researcher in the Science corpus: 20 papers; trusts 11 researchers and is trusted by 11 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 169 citations into it; #3,388 of 17,773 by trust here, #1,575 by citations

Whom Hyun-soo Cho trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. S. Hayami
2. Masanori Yoshimatsu
3. G. Toyokawa
4. Ryuji Hamamoto
5. John D. Kelly
6. Brian D. Strahl
7. C. D. Allis
8. Helen I. Field
9. T. Jenuwein
10. Tatsuhiko Tsunoda

Who trusts Hyun-soo Cho overall

1. Ryuji Hamamoto
2. Lianhua Piao
3. Makoto Nakakido
4. Takehiro Suzuki
5. G. Toyokawa
6. Yusuke Nakamura
7. N. Dohmae
8. Zhenzhong Deng
9. Daechun Kang
10. Xiaolan Deng

Papers from Hyun-soo Cho's perspective

Ordered by how strongly the researchers Hyun-soo Cho trusts endorse each paper. Same corpus, a different order for every researcher.

1. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
2. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. (Cell)
3. Regulation of chromatin structure by site-specific histone H3 methyltransferases (Nature)
4. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins (Nature)
5. The language of covalent histone modifications (Nature)
6. Histone methylation in transcriptional control. (Current Opinion in Genetics and Development)
7. Histone demethylation by a family of JmjC domain-containing proteins (Nature)
8. SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3* (Journal of Biological Chemistry)
9. Genome-wide map of nucleosome acetylation and methylation in yeast. (Cell)
10. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain (Nature)

Their papers

• Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers (2011) — 455 citations
• Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker (2011) — 190 citations
• Abstract 3019: Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells (2011) — 207 citations
• Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer (2011) — 114 citations
• Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. (2011) — 120 citations
• Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. (2012) — 179 citations
• Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B (2012) — 120 citations
• Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (2003) — 1,641 citations
• RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. (2012) — 196 citations
• Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. (2011) — 100 citations
• WHSC1 Promotes Oncogenesis through Regulation of NIMA-Related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck (2014) — 91 citations
• EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. (2003) — 793 citations
• The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6 (2011) — 68 citations
• Novel prognostic marker PRMT1 regulates cell growth via downregulation of CDKN1A in HCC (2017) — 31 citations
• The histone methyltransferase Wolf–Hirschhorn syndrome candidate 1‐like 1 (WHSC1L1) is involved in human carcinogenesis (2013) — 67 citations
• The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer (2018) — 35 citations
• GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands (2015) — 34 citations
• The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene (2012) — 96 citations
• Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India (2009) — 2,458 citations
• An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. (2003) — 955 citations